?>
WalkingHorse

🎶🎵 ...And she went down swingin'... 🎶🎵

N/A

WalkingHorse

Posting my cancer story so that I have a place to refer folks interested in my cancer backstory.

N/A

WalkingHorse

Postoperative Circulating Tumour DNA in Predicting Recurrence of Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational study

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Sophora compounds against non-small cell lung cancer: Research status and mechanisms

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Efficacy of PD-(L)1 inhibitors plus anlotinib in the second-line treatment of extensive-stage small cell lung cancer | BMC Cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Extracellular vesicle-associated epidermal growth factor receptor as a potential liquid biopsy biomarker in lung adenocarcinoma: a case-control study

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

An allele-specific quantitative PCR strategy for detection of EGFR T790M mutations by liquid biopsy in non-small cell lung cancer patients☆

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

ASO Visual Abstract: Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Sintilimab + Nab-PP Combined with Recombinant Human Vascular Endothelial Inhibitor for Locally Advanced/Advanced and Recurrent Metastatic Squamous Non-Small Cell Lung Cancer: Study Protocol for a Single-Arm, Multi-Centre Phase II Clinical Study

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

New therapeutic approaches for EGFR mutated non-small cell lung cancer on osimertinib era

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Causal Relationship between Omega-6/Omega-3 Fatty Acid Ratio and Risk of Lung Cancer: A Mendelian Randomization Study Base on A European Cohort

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

HRD1 regulates tumor-associated macrophage polarization through USP7 and promotes lung cancer development

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Sd-021, derivatives of decursin, inhibits tumorigenesis in NSCLC by inhibiting the EGFR/STAT3 signaling pathway

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy | BMC Cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Association between EGFR mutation types and incidence of brain metastases in postoperative patients with stage I–III NSCLC

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

LAPTM5 confers cisplatin resistance in NSCLC by suppressing LAMP1 ubiquitination to stabilize lysosomal membranes and sustain autophagic flux

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

SREBP-2 promotes cancer progression through the mevalonate-Akt pathway in non-small cell lung cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

ACR Appropriateness Criteria® Lung Cancer-Surveillance After Therapy

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Clinicopathological significance of sulfite oxidase expression in surgically resected lung adenocarcinoma

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Nutritional Approach on Management of Diarrhea Induced by EGFR-TKI’s in Advanced Non-Small Cell Lung Cancer Patients

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

Efficacy and safety of first-line chemoimmunotherapy in young patients with extensive-stage small cell lung cancer: a multicenter retrospective study | BMC Cancer

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

EXPRESS: CircZFR involves propofol-triggered ferroptosis in lung cancer cells through the IGF2BP2/GPX4 axis

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.

WalkingHorse

CKS1B regulates the radiosensitivity of lung cancer via activating the PI3K/AKT signaling pathway

Started as an alternative space while the main lung cancer sub was locked. Now both are up and running I will keep this up as a reading room with more quiet discussions and r/lungcancer, with its larger user base, as a place for more robust discussions. 🤍 Feel free to post relevant papers, studies, etc. Must relate to lung cancer. Thank you.